Medical Questionnaire and Tissue Banking For Multiple Myeloma, Waldenstrom Macroglobulinemia and Related Disorders
- Participants will be asked to complete a medical survey which includes demographics,
diagnosis, and treatment history, medical history, lab results and symptoms
- Participants will then receive instructions for the tissue banking procedure, which
involves donating bone marrow and blood samples. These will be collected only at times
when necessary clinical bone marrow samples are obtained and will not require an extra
visit to the doctor.
- The investigators are also requesting permission to collect medical information from
the participant's record and link this information to the specimens so that we may
better understand the participant's response to treatment. For samples obtained prior
to beginning therapy, this information might allow us to develop new ways of predicting
response to therapy. The investigators are also requesting permission to store samples
of blood and bone marrow to establish a tissue bank for future research to these
diseases. These samples will be de-identified; any of the participant's personal
health information identifiers will be removed.
- The tumor sample may be obtained at diagnosis, during treatment and/or as the time of
relapse. The timing of sample collection will coincide with other bone marrow tests
required to assess the response to therapy or any other clinical purpose.
Observational Model: Case-Only, Time Perspective: Prospective
To establish a databank of patients with MM, WM, MGUS, sMM, or related disorders. This databank will include medical history data and bone marrow and peripheral blood samples.
Irene Ghobrial, MD
Dana-Farber Cancer Institute
United States: Institutional Review Board
|Dana-Farber Cancer Institute||Boston, Massachusetts 02115|